Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination
Top Cited Papers
- 19 February 2021
- journal article
- editorial
- Published by Wiley in American Journal of Hematology
- Vol. 96 (5), 534-537
- https://doi.org/10.1002/ajh.26132
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Acute Immune Thrombocytopenia following administration of Shingrix recombinant zoster vaccineAmerican Journal of Hematology, 2021
- Familial thrombocytopenia flare‐up following the first dose of mRNA‐1273 Covid‐19 vaccineAmerican Journal of Hematology, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineThe New England Journal of Medicine, 2021
- Immune thrombocytopenia in a 22‐year‐old post Covid‐19 vaccineAmerican Journal of Hematology, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine, 2020
- Safety of antisense oligonucleotide and siRNA-based therapeuticsDrug Discovery Today, 2017
- Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported casesImmunologic Research, 2014
- A case-control study to assess the risk of immune thrombocytopenia associated with vaccinesBlood, 2012
- The Risk of Immune Thrombocytopenic Purpura After Vaccination in Children and AdolescentsPEDIATRICS, 2012
- Risk of Immune Thrombocytopenic Purpura After Measles-Mumps-Rubella Immunization in ChildrenPEDIATRICS, 2008